Botulinum toxin type E clinical trials
Also written EB-001.
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2016
How each study uses botulinum toxin type E is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
4 studies that test it; most in 2018 (2)
| Year | Studies |
|---|---|
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 4
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 0
Studies
Open first, then newest update. How each study uses botulinum toxin type E is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- Study to Evaluate Botulinum Neurotoxin Serotype E (EB-001) in Reducing Musculoskeletal Pain in AbdominoplastyTerminatedPhase 2AllerganNCT03429556Written as Botulinum Neurotoxin Serotype E
- Evaluate Safety and Efficacy of a Single Treatment Cycle of EB-001 in Subjects With Glabellar Frown LinesCompletedPhase 2Bonti, Inc.NCT02939326Written as EB-001 injection
- Study to Evaluate EB-001 in Reducing Musculoskeletal PainCompletedPhase 2Bonti, Inc.NCT03193593Written as EB-001
- Study of EB-001 in Facial Scar ReductionCompletedPhase 2Bonti, Inc.NCT03346902Written as EB-001
Codes
What other systems call botulinum toxin type E · ClinicalTrials.gg INT003873
- MeSH (NLM) C096326botulinum toxin type EOne source NLM
- UNII (FDA) T579M564JYBOTULINUM TOXIN TYPE EConfirmed FDA, NLM
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C096326 | botulinum toxin type E | One source NLM |
| UNII (FDA) | T579M564JY | BOTULINUM TOXIN TYPE E | Confirmed FDA, NLM |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.